Literature DB >> 25575696

The role of IL-21 in immunity and cancer.

Matthew R Davis1, Ziwen Zhu2, Dwayne M Hansen1, Qian Bai2, Yujiang Fang3.   

Abstract

Interleukin-21 (IL-21), produced predominantly by CD4+ T cells and natural killer T (NKT) cells, is a newly discovered member of the common γ-chain family of cytokines. It has been implicated in many immunological processes and has been linked to autoimmune diseases, allergies and other inflammatory diseases. In recent years, the role for IL-21 in the pathogenesis of cancer has also been extensively studied. In this review, we will discuss recent advances concerning the role of IL-21 in immunological processes and the pathogenesis of cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; IL-21; Immune response

Mesh:

Substances:

Year:  2015        PMID: 25575696     DOI: 10.1016/j.canlet.2014.12.047

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  46 in total

1.  Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma.

Authors:  Markus Granzin; Ana Stojanovic; Matthias Miller; Richard Childs; Volker Huppert; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

2.  Epigenetic Changes in Alveolar Type II Lung Cells of A/J Mice Following Intranasal Treatment with Lipopolysaccharide.

Authors:  Christopher L Seiler; Jung Min Song; Jenna Fernandez; Juan E Abrahante; Thomas J Y Kono; Yue Chen; Yanan Ren; Fekadu Kassie; Natalia Y Tretyakova
Journal:  Chem Res Toxicol       Date:  2019-04-16       Impact factor: 3.739

3.  Mechanism involved in interleukin-21-induced phagocytosis in human monocytes and macrophages.

Authors:  F Vallières; D Girard
Journal:  Clin Exp Immunol       Date:  2016-11-22       Impact factor: 4.330

Review 4.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

5.  Distribution of circulating follicular helper T cells and expression of interleukin-21 and chemokine C-X-C ligand 13 in gastric cancer.

Authors:  Xinying Meng; Xinjuan Yu; Quanjiang Dong; Xiaona Xu; Jinghua Li; Qianqian Xu; Jian Ma; Changhong Zhou
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

6.  The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer.

Authors:  Vivi A Ding; Ziwen Zhu; Timothy A Steele; Mark R Wakefield; Huaping Xiao; Dean Balabanov; Yujiang Fang
Journal:  Med Oncol       Date:  2017-12-05       Impact factor: 3.064

Review 7.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

8.  Germline mutations and blood malignancy (Review).

Authors:  Yuping Gong; Jili Deng; Xia Wu
Journal:  Oncol Rep       Date:  2020-11-11       Impact factor: 3.906

9.  Advances of the interleukin-21 signaling pathway in immunity and angiogenesis.

Authors:  Ming-Jie Yuan; Tao Wang
Journal:  Biomed Rep       Date:  2016-04-27

10.  Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  R Xing; Y Jin; L Sun; L Yang; C Li; Z Li; X Liu; J Zhao
Journal:  Clin Exp Immunol       Date:  2016-02-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.